Our Management Team

Grant D. Senner, MD, DABRM | Chief Executive Officer

Dr. Grant Senner, MD, DABRM is a tested physician executive and entrepreneur with more than fourteen years of progressive healthcare leadership experience and brings proven success in achieving strategic, operational and financial objectives. His diverse background includes expertise in biomedical technology and commercialization, health finance, clinical program development, medical reimbursement and population health management spanning the commercial and academic sectors.


Upon completion of his Doctorate, Dr. Senner served as Fellow and Consultant for the state of Arizona’s Medicaid agency where he focused on Centers for Medicare and Medicaid Services (CMS) reimbursement models and coordination of care for individuals with complex needs in a patient-centered model. Subsequently, he held key leadership positions within community-based medical practice and biomedical technology companies. In 2012, he joined University of Arizona Health Sciences, University of Arizona, as Director of Special Projects and Strategic Initiatives and was responsible for analysis of market opportunities and support of grant and contract development. Dr. Senner joined Amnio Technology in 2015 as Chief Strategy Officer and assumed duties as Chief Executive Officer in July of 2017.


An Honors graduate of the University of Arizona with a Bachelor of Science in Molecular and Cellular Biology, Dr. Senner attended the University of Arizona College of Medicine – Tucson and graduated with his Doctorate of Medicine in 2004. In 2014, his family established the Senner Endowment for Precision Health within University of Arizona Health Sciences, dedicated to support the use of genetic profiles to guide the diagnosis, prediction, treatment and prevention of disease. Dr. Senner has served on the Alumni Board of the University of Arizona College of Medicine – Tucson since 2010 and continues to serve as a member of Faculty within the Department of Family and Community Medicine.


Kent D. Krueger, CPA | Chief Financial Officer

Kent Krueger is a detailed, results-oriented, people-focused Certified Public Accountant (CPA). He has over 22 years corporate experience with American Express [AMEX] where he won a Chairman’s Award for Innovation and a Chairman’s Award for Cost Savings. He started at AMEX as a General Ledger Analyst in 1990 and continuously moved up to positions of increasing responsibility culminating in position as Finance Manager-Global Finance Operations Risk Management where served as relationship leader responsible for managing operations risk with AMEX Finance Partners. He is proficient at working as a team leader acting as liaison between a company, its internal departments, and outside vendors. Skilled at hands-on multi-tasking, problem-solving and in designing and implementing new financial methods and procedures in a fast-paced environment requiring quick thinking, attention to detail, and accuracy.


Graduated from Arizona State University in 1988 with a Bachelor of Science in Business.

Certified Public Accountant in Arizona since 1992

Arizona State Society of CPA – Tax Steering Committee Member

Arizona State Society of CPA – CPAs in Industry Steering Committee Member

Member of American Institute of Certified Public Accountants


Christian Beaudry, MBA, CTBS, DABRM | Chief Scientific Officer

Christian Beaudry is an executive and entrepreneur with more than eighteen years of biopharmaceutical and scientific research experience and brings proven success in developing and bringing to market novel biological products. His diverse background includes expertise in biomedical technology and commercialization, regulatory compliance, business operations, research and development, cellular biology, and scientific research spanning the commercial and academic sectors.

His professional experience includes directing and managing biopharmaceutical research facilities as well as conducting new product development and research investigations. Christian joined Amnio Technology in 2013 where he was instrumental in developing and bringing to market the company’s PalinGen® and ProMatrX ACF™ allograft product offerings. He assumed duties as Chief Scientific Officer in January of 2015 and is responsible for the overall research and development of new allografts and technologies.

Prior to joining Amnio Technology, Christian held various research and operation appointments and he is listed as an inventor on over 18 issued and pending patents and has published over 29 scientific articles and 2 book chapters. He earned a Master of Business Administration degree from the University of Phoenix, a Bachelor of Science degree in Medical Biology from the University of Quebec and he is a certified Tissue Bank Specialist by the American Association of Tissue Banks and Diplomat of the American Board of Regenerative Medicine.


Ann Kolesar, MBA | Director Quality and Compliance

Ann is a seasoned Quality Professional with over twenty years experience in FDA regulated industries, including manufacturing and aseptic processing in pharmaceutical, medical device, and biologics environments. She brings a diversified skill set with expertise in Quality Operations and International Regulatory Compliance.  Her experience includes direct oversight of Manufacturing, as well as management of Quality Systems and Compliance programs in virtual, traditional, and contract manufacturing environments under US and international regulation. Ann is a proven leader with demonstrated skills in problem solving, negotiation, and achievement of company and compliance objectives in complex and dynamic environments.  She attended Arizona State University and holds a B.S. in Biology, and an MBA.


Deanna Hunt | Director of Regulatory Affairs

Deanna has over fifteen years of Quality Assurance & Regulatory Affairs leadership experience in the medical industry, specializing in new product development, regulatory affairs compliance, quality system compliance, and US / OUS pre-market approval submissions.  Deanna is a hands-on, strategic, high energy individual with a great sense of perseverance.

As Director of Regulatory Affairs for Amnio Technology, LLC., Deanna is responsible for ensuring continued regulatory compliance for the business and product portfolio.  Prior to joining the AT family, Deanna has held joint QA & RA leadership positions where she has provided quality & regulatory oversight for a multitude of medical technologies including imaging catheters, surgical tools, implantable devices, IVDD’s, medical use pumps, single use devices, and cold plasma energy delivery devices.  During her career, Deanna has been instrumental in navigating the regulatory approval pathway for US / OUS pre-market submissions, including working directly with regulatory agencies on novel technologies and clinical indications.


Larry Macal, MBA | Operations Manager

Larry is currently responsible for operations at AmnioTechnology, LLC.

Larry has been in the medical products industry for over 25 years, serving in leadership roles related to new product development, operations, supply chain, supplier management, and continuous improvement.  Larry also has had previous responsibility for manufacturing based IT implementations, product transfers, and supply chain systems.

Larry has held other senior leadership roles within medical device companies in Minneapolis, MN, Flagstaff, AZ, and Switzerland along with, Puerto Rico, as Project Leader for Manufacturing Technology Transfer.

Larry holds Bachelor of Science degree in Business from Arizona State University and a MBA with emphasis in Operation from Ashford University.

Josh Cronin|Director of National Sales

Josh has over 27 years’ experience in the medical device sales industry. He graduated from the United States Military Academy at West Point in 1984 with a Bachelor of Science Degree. He was commissioned as an Infantry Officer and served with both the 101st Airborne Division and 3d Battalion, 75th Ranger Regiment. Upon leaving military service, Josh accepted a role with Walter Lorenz Surgical (currently Biomet Microfixation) and held various positions for the next 16 years including VP of United States sales where he
re-engineered the entire sales force from a direct model to a distributor model allowing for substantial growth and expansion.

Additionally, Josh has held senior leadership roles with Spinal Elements and recently with X-spine/Xtant medical where he started and grew the Biologics division for X-spine prior to their merger with Bacterin International.


Rachel L. Schwartz-Olson, CPA | Controller

Rachel Schwartz-Olson graduated in 1989 from Minnesota State University with a double major in Accounting and Finance.  In 1990, Rachel began her accounting and finance career in Phoenix, Arizona with Valley National Bank as a staff accountant.  Rachel obtained her Certified Public Accountant license in 1994.  Throughout her career at the bank, she was promoted to an Assistant Vice President/Accounting Manager in 1994, to Vice President/Finance Manager in 1997.   Additionally, while at the bank, she assisted in system conversions during the many bank mergers and acquisitions.  Rachel also assisted in the successful conversion and training of accounting departments around the country to a standard budgeting system.

Since 2001, Rachel has managed a corporate fiduciary business and a CPA business started by her and her husband.  She has successfully managed relationships with clients of both these companies and has numerous dealings with insurance companies, attorneys and banks as well as preparing client financial statements and tax returns.

In 2015, Rachel started in the accounting area with Amnio Technology and accepted a Controller position in November of 2016.  Rachel is dedicated to making Amnio Technology one of the premier businesses in their industry.